The growth of business for VNUS Medical Technologies has been significant since their VNUS Closure Fast technology hit the market. The technology provides a much more efficient and effective treatment for varicose veins than has ever been seen in the past. This has caused doctors and patients across the nation to take an interest in using this product.
As a result, the stocks for this company have been on the rise. Although smart investors got in on the product months ago, investment analysts are continuing to recommend that this is a stock worth investing in now.
The main reason for this is that this is a good product which serves the need of a growing community. VNUS believes that "72% of women and 42% of men in the United States will experience varicose veins by the time they hit 60". Because the baby boomer generation is currently aging into that bracket, this means that there are millions of people who are going to have an interest in removing varicose veins. That's a market that VNUS can serve.
VNUS Closure Fast is being used around the nation now. If you're considering getting vein treatment, you might want to make sure that this is what you're doctor has invested in.
Question of the Day: Would you agree that it's a good time to buy stock in VNUS?
